MoneyWorks4Me

The June 2026 quarter revenue stood at Rs. 2029.50 millions, up 11.16% as compared to Rs. 1825.70 millions during the corresponding quarter last year.Good  Net Profit growth of 40.16% reported above the corresponding previous quarter figure of Rs. 858.90 millions to Rs. 1203.80 millioins.Operating profit surged to 1572.00 millions from the corresponding previous quarter of 1186.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2029.50 1825.70 11.16 2029.50 1825.70 11.16 7383.30 7524.10 -1.87
Other Income 627.90 320.30 96.03 627.90 320.30 96.03 1953.70 1345.90 45.16
PBIDT 1572.00 1186.40 32.50 1572.00 1186.40 32.50 5331.50 4665.60 14.27
Interest 0.50 0.40 25.00 0.50 0.40 25.00 2.00 1.20 66.67
PBDT 1571.50 1186.00 32.50 1571.50 1186.00 32.50 5329.50 4664.40 14.26
Depreciation 65.60 61.40 6.84 65.60 61.40 6.84 254.30 247.70 2.66
PBT 1505.90 1124.60 33.91 1505.90 1124.60 33.91 5075.20 4416.70 14.91
TAX 302.10 265.70 13.70 302.10 265.70 13.70 1109.40 1021.80 8.57
Deferred Tax 14.50 -3.40 -526.47 14.50 -3.40 -526.47 14.50 -7.20 -301.39
PAT 1203.80 858.90 40.16 1203.80 858.90 40.16 3965.80 3394.90 16.82
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 152.00 0.00
PBIDTM(%) 77.46 64.98 19.20 77.46 64.98 19.20 72.21 62.01 16.45

Caplin Point Labs. Share Price

2480.60 -17.65 (-0.71%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: